Randomised phase IIa trial of CYT 003 QbG10 with or without grass pollen extract versus placebo in patients with mild to moderate seasonal allergic rhinitis due to grass pollen allergy.

Trial Profile

Randomised phase IIa trial of CYT 003 QbG10 with or without grass pollen extract versus placebo in patients with mild to moderate seasonal allergic rhinitis due to grass pollen allergy.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2007

At a glance

  • Drugs CMP 001 (Primary)
  • Indications Hypersensitivity; Seasonal allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Cytos Biotechnology
  • Most Recent Events

    • 14 Mar 2007 Interim results have been reported
    • 14 Mar 2007 Status changed from initiated to completed
    • 14 Jun 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top